Inogen, Inc (NASDAQ:INGN) Short Interest Update

Inogen, Inc (NASDAQ:INGN) was the recipient of a large increase in short interest during the month of February. As of February 27th, there was short interest totaling 1,208,558 shares, an increase of 24.2% from the February 12th total of 973,130 shares. Based on an average daily volume of 322,836 shares, the days-to-cover ratio is currently 3.7 days. Currently, 4.5% of the shares of the company are short sold. Currently, 4.5% of the shares of the company are short sold. Based on an average daily volume of 322,836 shares, the days-to-cover ratio is currently 3.7 days.

Institutional Trading of Inogen

A number of institutional investors have recently modified their holdings of INGN. Armistice Capital LLC purchased a new position in Inogen in the second quarter worth $4,668,000. CSM Advisors LLC acquired a new position in shares of Inogen during the 3rd quarter worth $2,973,000. Divisadero Street Capital Management LP grew its stake in shares of Inogen by 192.3% during the 2nd quarter. Divisadero Street Capital Management LP now owns 455,389 shares of the medical technology company’s stock worth $3,201,000 after purchasing an additional 299,571 shares during the period. GSA Capital Partners LLP purchased a new position in shares of Inogen in the 3rd quarter valued at about $1,397,000. Finally, Goldman Sachs Group Inc. lifted its stake in shares of Inogen by 37.6% in the fourth quarter. Goldman Sachs Group Inc. now owns 589,273 shares of the medical technology company’s stock valued at $3,960,000 after purchasing an additional 160,960 shares during the period. 89.94% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Inogen in a report on Monday, December 22nd. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $11.00.

Inogen Trading Up 1.2%

Shares of NASDAQ:INGN traded up $0.07 during midday trading on Monday, hitting $6.13. The stock had a trading volume of 203,670 shares, compared to its average volume of 358,775. Inogen has a 1 year low of $5.34 and a 1 year high of $9.13. The stock has a 50 day moving average price of $6.13 and a two-hundred day moving average price of $7.13. The company has a market capitalization of $166.92 million, a PE ratio of -7.13 and a beta of 1.76.

Inogen (NASDAQ:INGN) last posted its quarterly earnings results on Tuesday, February 24th. The medical technology company reported ($0.26) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.36) by $0.10. Inogen had a negative net margin of 6.52% and a negative return on equity of 11.56%. The firm had revenue of $81.72 million during the quarter, compared to analysts’ expectations of $82.00 million. As a group, equities analysts expect that Inogen will post -1.73 EPS for the current year.

About Inogen

Inogen, Inc (NASDAQ: INGN) is a medical device company specializing in the development, manufacture and marketing of innovative oxygen therapy solutions. The company’s core focus is on portable oxygen concentrators (POCs) designed to support patients with chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD). Inogen’s offerings aim to provide users with mobility and independence by reducing reliance on traditional compressed-gas cylinders and enabling oxygen therapy on the go.

Inogen’s flagship product line, including the Inogen One family of portable oxygen concentrators, leverages proprietary flow technology to deliver continuous and pulse-dose oxygen.